Please find enclosed herewith the Intimation for the Closure of the Trading Window w.e.f. Thursday, October 01, 2026.

September 29, 2026 To To The Manager, Listing Department The General Manager, Listing Department National Stock Exchange of India BSE Limited Plot no. C/1 G Block, Phiroze Jeejeebhoy Towers, Bandra-Kurla Complex, Bandra (East), Dalal Street, Mumbai- 400 051 Mumbai- 400 001 Symbol: BLISSGVS Scrip Code: 506197 Dear Sir/Madam, Subject: Intimation of Closure of Trading Window w.e.f. October 01, 2026 This is to inform you that pursuant to the Securities Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (including any statutory modification(s) or re-enactment(s) thereof, for the time being in force) and in accordance with the Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons, the Trading window for dealing in securities/shares of Bliss GVS Pharma Limited (“the Company”) will remain closed for Insiders, Designated Persons and their immediate relatives of the Company with effect from Thursday, October 01, 2026 till completion of 48 hours after the announcement of the Unaudited Financial Results of the Company for the quarter and half year ended on September 30, 2026 generally made available to the public. The Board meeting for the declaration of Unaudited Financial Results for the quarter and half year ended September 30, 2026, shall be intimated later. Accordingly, Insiders, Designated Persons, and their immediate relatives are advised not to trade (buy or sell or pledge, etc.) in the securities/shares of the Company during the aforesaid period of closure of the Trading Window. Kindly take the above information on record. Thanking you. Yours faithfully, For Bliss GVS Pharma Limited Aditi Bhatt Company Secretary